Trial of Brigatinib After Treatment With Next-Generation ALK Inhibitors

NCT02706626 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
32
Enrollment
INDUSTRY
Sponsor class

Stopped Did not meet enrollment objectives.

Conditions

Interventions

Sponsor

Criterium, Inc.

Collaborators